Press release - 04/10/2023 Therapeutic option for tumor patients with the rare DNAJB1-PRKACA gene fusion A phase I clinical trial is now starting at Tuebingen University Hospital in the Clinical Collaboration Unit (CCU) Translational Immunology, in collaboration with the Department of Internal Medicine I, which is investigating the therapeutic cancer peptide vaccine Fusion-VAC-XS15 in combination with immune checkpoint blockade by atezolizumab (Tecentriq®). https://www.gesundheitsindustrie-bw.de/en/article/press-release/therapeutic-option-tumor-patients-rare-dnajb1-prkaca-gene-fusion
Press release - 02/10/2023 Distributed artificial intelligence to improve patient care in the operating room A research team of scientists from the Fraunhofer IPA, the Bosch Digital Innovation Hub at Bosch Health Campus and the Institute of Image-Guided Surgery (IHU) of Strasbourg has jointly launched the DAIOR project. Within the framework of the project, the project partners are working on realizing the operating room of the future with help of artificial intelligence and robot assisted telemedicine. https://www.gesundheitsindustrie-bw.de/en/article/press-release/distributed-artificial-intelligence-improve-patient-care-operating-room
Help with osteoarthritis of the knee - 27/09/2023 Individualised knee-joint cartilage: artificial tissue that fits Knee joints are subject to considerable stress throughout our lives. The natural shock absorber cartilage wears out over a lifetime, so many people develop knee osteoarthritis. Treatment is available in the form of artificial cartilage. This "off-the-shelf" tissue often does not grow well. Researchers are developing an individualised cartilage replacement made from biomaterial that is produced by 3D printing based on MRI images.https://www.gesundheitsindustrie-bw.de/en/article/news/individualised-knee-joint-cartilage-artificial-tissue-fits
Event - 06/11/2023 - 09/11/2023 Black Forest Nanopore Meeting Freiburg im Breisgau, Kongress/Symposium https://www.gesundheitsindustrie-bw.de/en/event/black-forest-nanopore-meeting
Press release - 21/09/2023 Mutation-specific peptide vaccine against midline gliomas used in patients for the first time Tumor vaccines can help the body fight cancer. These vaccines alert the patient's immune system to proteins that are harbouring cancer-typical alterations. Physicians and cancer researchers from Heidelberg and Mannheim have now treated adult patients with advanced midline gliomas, difficult-to-treat brain tumors, with a peptide vaccine for the first time.https://www.gesundheitsindustrie-bw.de/en/article/press-release/mutation-specific-peptide-vaccine-against-midline-gliomas-used-patients-first-time
Press release - 19/09/2023 Better distinguish chronic inflammation and cancer of the pancreas Current diagnostic methods do not always reliably distinguish between chronic inflammation of the pancreas and pancreatic cancer. About one third of all diagnoses are inconclusive. Scientists from the German Cancer Research (DKFZ) and from Heidelberg University Hospital (UKHD) therefore searched for molecular markers that could specify this diagnosis.https://www.gesundheitsindustrie-bw.de/en/article/press-release/chronische-entzuendung-und-krebs-der-bauchspeicheldruese-praeziser-unterscheiden
Project SMARTGAIT - 13/09/2023 Safe and cost-effective analysis of neurological gait disorders with AI Stroke, Parkinson's disease and multiple sclerosis often resulting in gait disorders in those affected. Gait analyses play a crucial role in the successful evaluation and therapy of such disorders. Current measurement methods are costly and time-consuming. The SMARTGAIT project is therefore developing an innovative AI-based system aimed at performing meaningful gait analyses with the help of simple smartphone video recordings.https://www.gesundheitsindustrie-bw.de/en/article/news/safe-and-cost-effective-analysis-neurological-gait-disorders-ai
Funding IHI call 5 Funding programme, Funded by: Innovative Health Initiative (IHI) / Horizon Europe, sb_search.searchresult.label.programSubmissionDate: 16/01/2024 https://www.gesundheitsindustrie-bw.de/en/database/funding/ihi-call-5
Funding IHI call 4 Funding programme, Funded by: Innovative Health Initiative (IHI) / Horizon Europe, sb_search.searchresult.label.programSubmissionDate: 08/11/2023 https://www.gesundheitsindustrie-bw.de/en/database/funding/ihi-call-4
Sustainability report - 31/08/2023 ReKlimaMed: how effective is the German healthcare sector when it comes to sustainability? Hospitals, care facilities and the healthcare industry, together with laboratories, private practices and pharmacies, ensure our medical care, but in so doing they produce enormous amounts of greenhouse gases and consume many resources. The ReKlimaMed report prepared by the viamedica foundation presents an inventory of current sustainable activities, and provides stakeholders with information and recommendations for action.https://www.gesundheitsindustrie-bw.de/en/article/news/reklimamed-how-effective-german-healthcare-sector-when-it-comes-sustainability
Press release - 28/08/2023 Innovative computational approach helps design proteins for cancer treatment The computational design of new proteins for biomedical or other applications involves long computing times on powerful servers. A joint team of researchers from the Max Planck Institute for Biology Tübingen and the University Hospital Tübingen has now developed and tested a new computational method to greatly speed up the necessary energy calculations. Their framework allows for a precise and efficient design of functional proteins.https://www.gesundheitsindustrie-bw.de/en/article/press-release/innovative-computational-approach-helps-design-proteins-cancer-treatment
Event - 24/10/2023 - 25/10/2023 HEALTHTECH INNOVATION DAYS – HTID#5 Paris, Kongress/Symposium https://www.gesundheitsindustrie-bw.de/en/event/healthtech-innovation-days-htid5
Event - 12/12/2023 - 13/12/2023 Biofit 2023 Marseille (France), Messe https://www.gesundheitsindustrie-bw.de/en/event/biofit-2023
DNA nanotechnology - 25/08/2023 Artificial cytoskeleton made of DNA for synthetic cells The physicists Prof. Dr. Kerstin Göpfrich and Prof. Dr. Laura Na Liu want to understand life from the bottom up. They intend to do this by constructing an artificial cell. However, rather than natural protein building blocks, they are using 3D-DNA structures as construction material. The first step involved creating an artificial cell skeleton that dynamically assembles and disassembles like the biological model and can transport vesicles.https://www.gesundheitsindustrie-bw.de/en/article/news/artificial-cytoskeleton-made-dna-synthetic-cells
Event - 10/10/2023 - 11/10/2023 MedFIT 2023 Strasbourg (France), Messe https://www.gesundheitsindustrie-bw.de/en/event/medfit-2023
Press release - 18/08/2023 TÜV SÜD gets UK Approved Body designation TÜV SÜD has received approval as a UK Approved Body (UKAB) for medical devices. With this approval, medical device manufacturers can implement UKCA certification for the UK market and CE certification for the European market in a time- and cost-efficient manner with TÜV SÜD.https://www.gesundheitsindustrie-bw.de/en/article/press-release/tuev-sued-gets-uk-approved-body-designation
Event - 15/11/2023 Networking Evening | Baden-Württemberg meets United Kingdom 2023 Medica trade fair, Baden-Württemberg joint booth K16, Hall 15, Messe https://www.gesundheitsindustrie-bw.de/en/event/networking-evening-baden-wuerttemberg-meets-united-kingdom-2023
Event - 04/10/2023 - 06/10/2023 BioTechX Europe 2023 Basel (Switzerland), Kongress/Symposium https://www.gesundheitsindustrie-bw.de/en/event/biotechx-europe-2023
Event - 28/09/2023 Life Science Investors’ Day 2023 Heidelberg (Germany), Kongress/Symposium https://www.gesundheitsindustrie-bw.de/en/event/life-science-investors-day-1
Event - 26/09/2023 - 28/09/2023 Ilmac Basel 2023 Basel (Switzerland), Messe https://www.gesundheitsindustrie-bw.de/en/event/ilmac-basel-2023
Event - 27/09/2023 - 29/09/2023 World Smart Bioprocessing: Pharma 4.0 Summit Berlin (Germany), Summit https://www.gesundheitsindustrie-bw.de/en/event/world-smart-bioprocessing-pharma-40-summit
Press release - 10/08/2023 Computer-aided cell analysis for faster diagnosis of blood diseases Scientists from the German Cancer Research Center (DKFZ) and the Cambridge Stem Cell Institute have developed an AI system that recognizes and characterizes white and red blood cells in microscopic images of blood samples. The algorithm can help physicians diagnose blood disorders and is available as an open source method for research purposes.https://www.gesundheitsindustrie-bw.de/en/article/press-release/computergestuetzte-zellanalyse-fuer-die-schnellere-diagnose-von-blutkrankheiten
Press release - 07/08/2023 Vegan trend in Europe: In Germany, milk substitutes from plants are most popular alternative Germany has the most active market, Southern Europe wants more variety, and people in Poland find dairy substitutes too expensive, according to a recent study by the University of Hohenheim.https://www.gesundheitsindustrie-bw.de/en/article/press-release/vegan-trend-europe-germany-milk-substitutes-plants-are-most-popular-alternative
Overview Press release was not found https://www.gesundheitsindustrie-bw.de/en/article/press-release/press-release-was-not-found
Overview Dossier was not found https://www.gesundheitsindustrie-bw.de/en/article/dossier/dossier-was-not-found